Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms |
Target- |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H16F3NO3S |
InChIKeyLBFQCSHNINDENX-ULWFUOSBSA-M |
CAS Registry1367346-14-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diagnostic agents | Phase 2 | - | - |